Pfizer And Blackstone Life Sciences Agree Up To $1.5B In Funding Through 2028 For Obesity Programme - Sources
Pfizer Retains Full Operational Control Of Berobenatide Programme - Blackstone Eligible For Payments Tied To Regulatory Approval And Sales Milestones